<DOC>
	<DOCNO>NCT00002692</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Randomized phase III trial compare effectiveness intravenous infusion intrahepatic infusion fluorouracil leucovorin treat patient colorectal cancer metastatic liver .</brief_summary>
	<brief_title>Intravenous Compared With Intrahepatic Chemotherapy Treating Patients With Colorectal Cancer Metastatic Liver</brief_title>
	<detailed_description>OBJECTIVES : I . Compare survival response rate patient colorectal liver metastasis treat intravenous vs. intrahepatic arterial infusion fluorouracil/leucovorin . II . Assess effect 2 treatment symptoms quality life patient . OUTLINE : Randomized study . Patients randomize Arm II preoperative hepatic angiography ; laparotomy , intrahepatic arterial catheter fuse gastroduodenal artery establish infusion lobe liver . Arm I : Single-Agent Chemotherapy Drug Modulation . Fluorouracil , 5-FU , NSC-19893 ; Leucovorin calcium , CF , NSC-3590 . Intravenous infusion . Arm II : Single-Agent Chemotherapy Drug Modulation . 5-FU ; CF . Intrahepatic arterial infusion . PROJECTED ACCRUAL : 312 patient expect randomized within 3-4 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma colon rectum metastasis confine liver amenable surgery PATIENT CHARACTERISTICS : Age : Any age Performance status : WHO 02 Life expectancy : More 3 month Hematopoietic : WBC least 3,000/mm3 Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 3.5 mg/dL ( 50 micromoles/liter ) Renal : Not specify Cardiovascular : No uncontrolled heart disease ( e.g. , congestive heart failure , angina ) Other : No uncontrolled infection No uncontrolled medical illness PRIOR CONCURRENT THERAPY : No prior fluorouracil ( 5FU ) advance disease More 6 month since adjuvant 5FU ( e.g. , AXIS QUASAR study )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>liver metastasis</keyword>
</DOC>